EP 2507260 A1 20121010 - OFA/ILRP DERIVED MODIFIED PEPTIDE
Title (en)
OFA/ILRP DERIVED MODIFIED PEPTIDE
Title (de)
OFA/ILRP-ABGELEITETES MODIFIZIERTES PEPTID
Title (fr)
PEPTIDE MODIFIÉ DÉRIVÉ À OFA/ILRP
Publication
Application
Priority
- EP 09014931 A 20091202
- EP 2010068280 W 20101126
- EP 10785044 A 20101126
Abstract (en)
[origin: EP2330122A1] The present invention relates to a novel modified human oncofoetal antigen immature laminin receptor (OFA/iLR) derived peptide comprising the sequence VLIENPADV and its use for diagnostic and therapeutic purposes, specifically in cancer.
IPC 8 full level
C07K 14/47 (2006.01)
CPC (source: EP)
C07K 14/47 (2013.01)
Citation (search report)
See references of WO 2011067175A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2330122 A1 20110608; EP 2507260 A1 20121010; WO 2011067175 A1 20110609
DOCDB simple family (application)
EP 09014931 A 20091202; EP 10785044 A 20101126; EP 2010068280 W 20101126